• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 15
  • 2
  • 1
  • 1

PRICE

0
2
3
19

PUBLISHED

1
1
12
19

PRODUCT TYPE

16
3

Search "Neotropix, Inc.-Detailed Product Pipeline" returned 19 results.

PRODUCT TITLE
Neotropix, Inc. - Product Pipeline Review - 2012 Neotropix, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Neotropix, Inc. - Product Pipeline Review - 2012

Neotropix, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - 2012” provides data on the Neotropix, Inc.’s research...

September 2012
FROM
Neotropix, Inc. - Product Pipeline Review - Q4 2010 Neotropix, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Neotropix, Inc. - Product Pipeline Review - Q4 2010

Neotropix, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Neotropix, Inc. - Product Pipeline Review - Q4 2010

Neotropix, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Neotropix, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Rhabdomyosarcoma - Pipeline Review, H2 2014

Rhabdomyosarcoma - Pipeline Review, H2 2014 Summary This, ‘Rhabdomyosarcoma - Pipeline Review, H2 2014’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This report provides...

December 2014
FROM
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 - Product Thumbnail Image

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Summary This, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014’, provides an overview of the...

November 2014
FROM

Retinoblastoma - Pipeline Review, H2 2014

Retinoblastoma - Pipeline Review, H2 2014 Summary This, ‘Retinoblastoma - Pipeline Review, H2 2014’, provides an overview of the Retinoblastoma’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Retinoblastoma - Pipeline Review, H1 2014

Retinoblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H1 2014’, provides an overview of the Retinoblastoma’s therapeutic pipeline. This report...

May 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2014

Small-Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

July 2014
FROM

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

April 2014
FROM
Lung Cancer - Pipeline Review, H2 2012 Lung Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Lung Cancer - Pipeline Review, H2 2012

Lung Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2012
FROM

Rhabdomyosarcoma - Pipeline Review, H1 2014

Rhabdomyosarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2014’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This...

June 2014
FROM

Neuroblastoma - Pipeline Review, H1 2014

Neuroblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report...

February 2014
FROM

Neuroblastoma - Pipeline Review, H2 2014

Neuroblastoma - Pipeline Review, H2 2014 Summary This, ‘Neuroblastoma - Pipeline Review, H2 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H1 2014

Non-Small Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Non-Small Cell Lung Cancer’s...

March 2014
FROM

Squamous Cell Carcinoma - Pipeline Review, H2 2014

Squamous Cell Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Squamous Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Squamous Cell Carcinoma’s therapeutic pipeline. This...

October 2014
FROM

Squamous Cell Carcinoma - Pipeline Review, H1 2014

Squamous Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Squamous Cell Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Squamous Cell Carcinoma’s therapeutic...

April 2014
FROM

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and...

March 2015
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.